4N85
Crystal structure of human transthyretin
4N85 の概要
| エントリーDOI | 10.2210/pdb4n85/pdb |
| 関連するPDBエントリー | 4N86 4N87 |
| 分子名称 | Transthyretin, CALCIUM ION (3 entities in total) |
| 機能のキーワード | thyroxine binding, transport protein |
| 由来する生物種 | Homo sapiens (human) |
| 細胞内の位置 | Secreted: P02766 |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 34741.27 |
| 構造登録者 | |
| 主引用文献 | Yokoyama, T.,Kosaka, Y.,Mizuguchi, M. Crystal structures of human transthyretin complexed with glabridin J.Med.Chem., 57:1090-1096, 2014 Cited by PubMed Abstract: Transthyretin (TTR) is a plasma protein implicated in human amyloid diseases. Several small molecules that bind to the thyroxine-binding site of TTR have been shown to stabilize the TTR tetramer and to inhibit amyloid fibril formation of TTR. Herein, we demonstrated that glabridin (Glab), a prenylated isoflavan isolated from Glycyrrhiza glabra L., inhibited aggregation of TTR in a thioflavin assay. The TTR-Glab complex structure revealed a novel binding mode including a CH-π interaction with A108 and a hydrogen bond with K15. A structural comparison with the wild type-apo structure revealed that the CH-π interaction with A108 was strengthened by the induced-fit conformational change upon Glab binding. Furthermore, the binding of Glab induced a rotation of the T119 side chain, and the inclusion of a water molecule, leading to stabilization of the dimer-dimer interface. These results demonstrate that Glab is a novel inhibitor of TTR fibrillization and suggest the molecular mechanism by which Glab binding stabilizes the tetramer. PubMed: 24422526DOI: 10.1021/jm401832j 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.6 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






